Patient Body Composition in Oncology Trials Implementation

This document is a case study that discusses the implementation of body composition assessments in oncology trials. It outlines the clinical applications of body composition, emphasizing its significance in improving prognostication and personalizing therapies for cancer patients. The study details various imaging modalities available for assessing body composition, such as Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and Dual-energy X-ray Absorptiometry (DXA), highlighting their respective advantages and limitations. The integration of body composition metrics into clinical workflows is explored, showcasing how it can enhance the efficiency of oncologic assessments. Furthermore, the document addresses the cost-effectiveness of utilizing body composition assessments, particularly in reducing patient dropout rates during trials. It concludes by advocating for the adoption of body composition as a standard practice in oncology, suggesting that the industry should embrace this biomarker to improve clinical outcomes and patient care. The study references various clinical evidences and emphasizes the need for standardized imaging protocols.